You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API oritavancin

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing oritavancin

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
The Medicines Company	ORBACTIV	oritavancin	65293-015	MANNITOL	2024-08-06
The Medicines Company	ORBACTIV	oritavancin	65293-015	PHOSPHORIC ACID	2024-08-06
Melinta Therapeutics LLC	ORBACTIV	oritavancin	70842-140	MANNITOL	2024-08-06
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for oritavancin

Excipient focus: HYDROXYPROPYL BETADEX

oritavancin drug variants containing HYDROXYPROPYL BETADEX

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Melinta Therapeutics LLC	oritavancin diphosphate	70842-225
>Company	>Ingredient	>NDC

oritavancin drug variants not containing HYDROXYPROPYL BETADEX

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
The Medicines Company	oritavancin	65293-015
Melinta Therapeutics LLC	oritavancin	70842-140
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

oritavancin drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
The Medicines Company	oritavancin	65293-015
Melinta Therapeutics LLC	oritavancin	70842-140
Melinta Therapeutics LLC	oritavancin diphosphate	70842-225
>Company	>Ingredient	>NDC

oritavancin drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PHOSPHORIC ACID

oritavancin drug variants containing PHOSPHORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
The Medicines Company	oritavancin	65293-015
Melinta Therapeutics LLC	oritavancin	70842-140
Melinta Therapeutics LLC	oritavancin diphosphate	70842-225
>Company	>Ingredient	>NDC

oritavancin drug variants not containing PHOSPHORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

oritavancin drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Melinta Therapeutics LLC	oritavancin diphosphate	70842-225
>Company	>Ingredient	>NDC

oritavancin drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
The Medicines Company	oritavancin	65293-015
Melinta Therapeutics LLC	oritavancin	70842-140
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.